Data / Form D filings / Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc.: Form D filings
Castle Creek Biosciences, Inc., a biotechnology company in Exton, PA, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on February 25, 2025, reports $75 million sold of a $75 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 405 Eagleview Boulevard, Exton, PA, 19341
- Phone
- (484) 713-6910
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1756702
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | New notice | $75,000,000 | $75,000,000 | 30 | Feb 24, 2025 | sec.gov | |
| May 2, 2022 | New notice | $112,782,892 | $112,782,892 | 54 | Apr 19, 2022 | sec.gov | |
| Feb 3, 2022 | New notice | $11,850,000 | $11,850,000 | 6 | Jan 18, 2022 | sec.gov | |
| Jul 9, 2021 | New notice | $25,000,000 | $25,000,000 | 36 | Jun 28, 2021 | sec.gov | |
| Jan 21, 2020 | New notice | $54,602,249 | $54,602,249 | 12 | Dec 9, 2019 | sec.gov | |
| Oct 24, 2018 | New notice | $560,544,226 | $560,544,226 | 19 | Oct 9, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Brill | Director | |
| Matthew Crabtree | Director | |
| Jeffrey Aronin | Director | |
| Matthew Gantz | Executive Officer, Director | |
| Patrick Morris | Director | |
| Jude Sullivan | Executive Officer | |
| Darien Parhad | Executive Officer | |
| Antonio Gracias | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Feb 24, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Castle Creek Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.